Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: A randomized placebo-controlled study
- 15 March 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 17 (4) , 956-962
- https://doi.org/10.1016/0735-1097(91)90879-e
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Reduction of infarct size estimated enzymatically in patients with acute myocardial infarction after treatment with recombinant tissue type plasminogen activator or after spontaneous coronary recanalisation: A randomised, placebo controlled studyFibrinolysis, 1990
- A new assay for the determination of factor XII in plasma using a chromogenic substrate and a selective inhibitor of plasma kallikreinThrombosis Research, 1989
- Role of the Contact System in FibrinolysisSeminars in Thrombosis and Hemostasis, 1987
- Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kallikrein “like” activity in human plasmaThrombosis Research, 1982
- The use of evacuated glass tubes for collection of blood samples for fibrinolytic assaysThrombosis Research, 1982
- Relationship between tissue plasminogen activator and the activators in blood and vascular wallThrombosis Research, 1980